Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SRZN · against 1,216 other Healthcare companies
Ranked #1,102 of 1,217 · scores higher than 9% of peers
Bars: peers in each 10-point band of the growth score116 peers with a growth score of 0–9, including SRZN · Click a bar to see the companies
Mainly because of its 3-year revenue growth, earnings per share growth and revenue growth, which are weaker than most Healthcare peers.
| Metric | SRZN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -8.8% | 6.1% | 17% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -34.7% | 5.8% | 3% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,102 | 2.5B CNY (≈$355M) | 9 | 24 | |
| 1,102 | 5.9B CNY (≈$824M) | 9 | 26 | |
| 1,102 | 3.7B USD | 9 | 24 | |
| 1,102 | 5.7B USD | 9 | 38 | |
| 1,102 | 354M USD | 9 | 13 | |
| 1,114 | 2.5B CNY (≈$349M) | 8 | 27 | |
| 1,114 | 1.9B CNY (≈$262M) | 8 | 24 | |
| 1,114 | 8.1B TWD (≈$251M) | 8 | 69 | |
| 1,114 | 6.9B CNY (≈$967M) | 8 | 26 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score